Autopsy report · NCT04020198
A Pilot Biomarker Study Assessing Alpha-synuclein Aggregates Across Biofluid Reservoirs in Patients With Synucleinopathies
Cause of deathOther
“The assay under investigation did not show evidence of accurately detecting alpha-synuclein in specimens collected in the study other than CSF and the intention of the study was to identify less invasive ways to measure alpha-synuclein.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 2 years 9 months before it stopped.
- 8 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- Stony Brook University
- Sponsor type
- University, hospital or other
- Conditions
- Parkinson Disease; Multiple System Atrophy; Rapid Eye Movement Sleep Behavior Disorder; Normal Pressure Hydrocephalus
- Interventions
- Biomarker assay
- Participants
- 8
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.